Cell Therapeutics, Inc.
501 Elliott Avenue West
Suite 400
Seattle,
WA 98119
United States - Map
Phone: 206-282-7100
Fax: 206-284-6206
Web Site: http://www.cticseattle.com
| Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkins lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers. It has collaboration and licensing arrangements with Novartis International Pharmaceutical, Ltd.; and PG-TXL Company, L.P. The company was founded in 1991 and is headquartered in Seattle, Washington. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. James A. Bianco M.D., 52
Principal Founder, Chief Exec. Officer and Exec. Director |
$
1.23M |
$
0 | Mr. Craig W. Philips , 48
Pres |
$
234.00K |
$
0 | Dr. Jack W. Singer M.D., 66
Founder, Chief Medical Officer, Exec. VP and Exec. Director |
$
493.00K |
$
0 | Mr. Louis A. Bianco CPA, 56
Co-Founder, Principal Financial Officer, Principal Accounting Officer and Exec. VP of Fin. & Admin. and Sec. |
$
495.00K |
$
0 | Mr. Dan Eramian , 61
Exec. VP of Corp. Communications |
$
456.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.16% Nasdaq 
Profile
